{
    "2018-08-31": [
        [
            {
                "time": "2018-07-31",
                "original_text": "How Eli Lilly’s Business Segments Performed in Q2 2018",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Q2",
                        "Business Segments"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-01",
                "original_text": "Glaxo's Asthma Drug Gets EU Nod for Pediatric Population",
                "features": {
                    "keywords": [
                        "Glaxo",
                        "Asthma Drug",
                        "EU Nod",
                        "Pediatric"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-08-02",
                "original_text": "Analyzing Eli Lilly’s Q2 2018 Revenue Trend",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Q2",
                        "Revenue Trend"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-03",
                "original_text": "Glaxo's Asthma Drug Gets EU Nod for Pediatric Population",
                "features": {
                    "keywords": [
                        "Glaxo",
                        "Asthma Drug",
                        "EU Nod",
                        "Pediatric"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-08-30",
                "original_text": "Eli Lilly’s Valuation on August 30",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Valuation"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-01",
                "original_text": "Biotech Stocks Facing FDA Decision In September",
                "features": {
                    "keywords": [
                        "Biotech Stocks",
                        "FDA Decision",
                        "September"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}